Femme et Homme
- | Pays :
- United States
- | Organes : -
- | Spécialités : -
Extrait
This trial is conducted in the United States of America (USA). The aim of the trial is to evaluate continuous subcutaneous infusion of NN1218 formulations and NovoLog® in subjects with type 1 diabetes.
Critère d'inclusion
- diabetes ,Diabetes Mellitus, Type 1